January 9, 2013
Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation that may have important implications for the lives of patients with late-stage disease.
January 7, 2013
The National Cancer Institute (NCI) has awarded the UCSF Helen Diller Family Comprehensive Cancer Center a $36 million grant to support cutting-edge research programs and clinical trials over five years.
January 4, 2013
The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness is reported this week by a team of researchers at UCSF.
December 20, 2012
UCSF is a health-sciences research powerhouse – a premier academic medical center that values not only the physician who designs clinical trial protocols for promising experimental drugs, but also the talented lab scientist who unearths nature’s secrets on the molecular and cellular levels.
December 19, 2012
As the year comes to a close, HDFCCC director Frank McCormick extends a thank you to our donors for a year of philanthropy.
December 18, 2012
VIDEO: View the UCSF Helen Diller Family Comprehensive Cancer Center Showcase 2012 opening plenary session.
December 17, 2012
Drugs and medical devices tend to appear more beneficial in scientific papers if they were manufactured by the company that sponsored the study, showing that who pays for the clinical trial has a direct impact on the reported outcome, according to a new analysis by researchers at UCSF and the Cochrane Collaboration.
December 13, 2012
St. Joseph's Medical Center is bringing advanced cancer care to San Joaquin County with a new collaboration between St. Joseph's Regional Cancer Center and the UCSF Helen Diller Family Comprehensive Cancer Center that will enhance patient care and access to clinical trials.
December 12, 2012
The pelvic exam, a standard part of a woman's gynecologic checkup, frequently is performed for reasons that are medically unjustified, according to the authors of a UCSF study that may lay the groundwork for future changes to medical practice.
December 11, 2012
President Barack Obama announced his intent to nominate UCSF's Mack Roach III, MD, FACR, an internationally recognized expert on using radiation to treat and manage prostate cancer, to the National Cancer Advisory Board.